Valuation: Photocure ASA

Market Cap 1.46B 156M 133M 125M 114M 215M 14.92B 219M 1.48B 576M 7.48B 585M 573M 24.75B P/E 2026 *
19.1x
P/E 2027 * 69.4x
Enterprise Value 1.29B 138M 118M 110M 101M 190M 13.19B 194M 1.31B 509M 6.61B 517M 506M 21.88B EV / Sales 2026 *
1.96x
EV / Sales 2027 * 1.95x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.18%
1 week-4.42%
Current month+1.89%
1 month-4.09%
3 months-18.06%
6 months-8.01%
Current year-24.37%
1 week 53.6
Extreme 53.6
60.5
1 month 46.25
Extreme 46.25
60.5
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Tech/Sci/R&D Officer - 2021-07-31
Human Resources Officer - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Date Insider Type Main position Quantity % Market Cap.
4/2/25 BuyCompany 11,355 0.0419%
4/2/25 BuyCompany 8,997 0.0332%
3/31/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%-4.42%-12.48%+29.81% 156M
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.56%+4.39%+25.19%+74.39% 463B
-1.20%+3.18%+39.58%+44.08% 371B
-1.00%+2.06%+21.49%+38.84% 301B
-0.38%+4.82%-0.30%+12.54% 256B
-1.95%+3.80%+46.31%+65.66% 234B
-0.19%+0.07%-17.19%-53.24% 205B
-2.82%+3.84%+20.81%+89.04% 178B
Average -0.43%+2.82%+24.93%+48.39% 376.12B
Weighted average by Cap. -0.15%+3.26%+42.65%+69.96%

Financials

2026 *2027 *
Net sales 658M 70.49M 60.35M 56.31M 51.67M 97.09M 6.74B 99M 668M 260M 3.38B 265M 259M 11.19B 666M 71.34M 61.08M 56.99M 52.3M 98.27M 6.83B 100M 676M 264M 3.42B 268M 262M 11.33B
Net income 76.33M 8.17M 7M 6.53M 5.99M 11.26M 782M 11.48M 77.45M 30.19M 392M 30.69M 30.02M 1.3B 21M 2.25M 1.93M 1.8M 1.65M 3.1M 215M 3.16M 21.31M 8.31M 108M 8.44M 8.26M 357M
Net Debt -169M -18.09M -15.49M -14.45M -13.26M -24.92M -1.73B -25.41M -171M -66.85M -868M -67.94M -66.46M -2.87B -157M -16.81M -14.39M -13.43M -12.32M -23.15M -1.61B -23.61M -159M -62.1M -806M -63.12M -61.74M -2.67B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-08-21 NOK 54.00 -0.18% 30,776
26-08-20 NOK 54.10 +0.19% 54,007
26-08-19 NOK 54.00 -2.88% 154,967
26-08-18 NOK 55.60 -3.30% 96,514
26-08-17 NOK 57.50 +1.77% 320,703
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
54.10NOK
Average target price
79.67NOK
Spread / Average Target
+47.26%

Quarterly revenue - Rate of surprise